Legal status · Australia
Is ANP legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. ANP is not an approved medicine in Australia; its classification is "Not registered". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile.
ANP in Australia at a glance
| Classification | Not registered |
|---|---|
| TGA approval status | Not approved by TGA |
| Human studies cited | 6 of 7 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the ANP profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing ANP is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What ANP is
The hormone the heart releases when its chambers stretch, and the reason the heart counts as an endocrine organ. Its recombinant form, carperitide, is used for acute heart failure in Japan; a 2025 meta-analysis of 9 studies found higher in-hospital mortality in carperitide-treated patients when randomised and propensity-matched studies were pooled.
Atrial natriuretic peptide is a 28 amino acid peptide, sequence SLRRSSCFGGRMDRIGAQSGLGCNSFRY, released from atrial cells when the chamber wall is stretched. It makes the kidney excrete sodium and water, relaxes blood vessels and opposes the renin-angiotensin system.
Mechanism: In humans, ANP binds NPR-A (gene NPR1), a particulate guanylyl cyclase, raising cyclic GMP in vascular smooth muscle and kidney tubule cells. The results are natriuresis, diuresis and vasodilation, plus suppression of renin and aldosterone.
Regulatory history: Not FDA approved. No ANP or carperitide product was returned by the Drugs@FDA query on 11 September 2026. Carperitide is described in the clinical literature as in use for acute heart failure in Japan; this site did not verify that approval with the Japanese regulator and does not state its date or terms.
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for ANP at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
ANP in other countries
Frequently asked questions
Is ANP legal in Australia?
No. ANP is not an approved medicine in Australia; its classification is "Not registered". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile.
Can I buy ANP in Australia?
No approved product exists to buy. In Australia ANP is classified as "Not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is ANP TGA approved?
No. In Australia ANP is classified as "Not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Not FDA approved. No ANP or carperitide product was returned by the Drugs@FDA query on 11 September 2026. Carperitide is described in the clinical literature as in use for acute heart failure in Japan; this site did not verify that approval with the Japanese regulator and does not state its date or terms.. On the evidence, 6 human studies are cited on its profile.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for ANP live on its compound profile.
ANP profileThis page is general information about the regulatory status of ANP in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.